Brookton Labs' GellX™patent-pending, non-toxic, supercritical extraction technology produces up to five novel extracts of Nigella sativa seeds simultaneously. The Company then combines these extracts in varying amounts based on biological and analytical assays. This proprietary combination process optimizes the final formulation for use in specific topical or systemic indications, resulting in commercial products with greater consistency and efficacy than has ever been achieved with N. sativa extracts or whole seeds.
For example, when we formulated our topical, rapid relief lotion DogsBestFriend, our GellX™ technology allowed us to minimize the introduction of potential allergens in N. sativa. The result is a soothing lotion with low allergic potential.